Avanos Medical Inc (AVNS)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	619,900	735,200	767,700	802,100	810,000	788,200	772,300	757,500	741,300	731,000	729,200	703,100	699,300	702,400	688,900	698,200	682,600	663,500	656,500	638,800
Receivables	US$ in thousands	142,800	145,200	152,300	142,700	167,900	146,200	145,400	161,600	131,200	132,900	168,800	168,500	167,900	182,300	137,800	188,500	163,800	157,700	124,300	135,000
Receivables turnover		4.34	5.06	5.04	5.62	4.82	5.39	5.31	4.69	5.65	5.50	4.32	4.17	4.16	3.85	5.00	3.70	4.17	4.21	5.28	4.73

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $619,900K ÷ $142,800K
= 4.34

Avanos Medical Inc's receivables turnover has shown fluctuations over the past eight quarters. The company's ability to efficiently collect payments from its customers can be analyzed using the receivables turnover ratio.

For the most recent quarter, Q4 2023, the receivables turnover ratio was 4.71. This indicates that, on average, Avanos Medical Inc collected its accounts receivable approximately 4.71 times during the quarter.

Comparing this ratio to the previous quarters, we see variations in the efficiency of receivables collection. The highest turnover ratio was observed in Q1 2023 at 5.71, suggesting a more efficient collection process during that period. However, in Q2 2022, the ratio was 5.35, indicating a similar level of efficiency as seen in Q3 2023.

Overall, while there have been fluctuations in Avanos Medical Inc's receivables turnover ratio over the past eight quarters, the company generally maintains a consistent level of efficiency in collecting payments from its customers. Monitoring and analyzing these trends can provide insights into the company's working capital management and overall financial performance.